Corpus Intelligence IC Memo — KFH - WALNUT CREEK 2026-04-26 19:06 UTC
IC Memo — KFH - WALNUT CREEK
Investment Committee Memorandum | CA | 219 beds | Grade B | EBITDA uplift $50.1M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

KFH - WALNUT CREEK

CCN 050072 | CONTRA COSTA, CA | 219 beds | April 26, 2026
EBITDA BridgeData Room
B
Investability

1. Target Overview & Investment Thesis

KFH - WALNUT CREEK is a 219-bed suburban community hospital in CONTRA COSTA, CA with $681.0M in net patient revenue and a -3.4% operating margin. The hospital serves a payer mix of 3.1% Medicare, 1.1% Medicaid, and 95.8% commercial.

Thesis: Undervalued. Our ML models identify $50.1M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -3.4% to 3.9% (+736bps).

Net Revenue HCRIS$681.0M
Current EBITDA COMPUTED$-23.4M
Operating Margin COMPUTED-3.4%
Occupancy HCRIS61.6%
Revenue / Bed COMPUTED$3.1M
Net-to-Gross HCRIS28.4%
Distress Probability ML41.1%

2. Market Context & Competitive Position

414
CA Hospitals
-4.9%
State Median Margin
206
Comparable Hospitals

CA has 414 Medicare-certified hospitals with a median operating margin of -4.9%. The target's margin of -3.4% places it above the state median. Among 206 size-comparable peers (110-438 beds), the median margin is -4.0%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (110-438), prioritizing same-state peers. 206 hospitals in the comp set.

HospitalStateBedsRevenueMargin
KFH - WALNUT CREEK (Target)CA219$681.0M-3.4%
LUCILE PACKARD CHILDRENS HOSPICA394$2.39B-0.8%
UCI MEDICAL CENTERCA397$1.90B-2.5%
CITY OF HOPE NATIONAL MEDICAL CA217$1.83B-10.7%
RADY CHILDRENS HOSPITAL - SAN CA401$1.82B14.8%
HARBOR-UCLA MEDICAL CENTERCA369$1.54B-6.4%
EL CAMINO HOSPITALCA388$1.34B11.7%
CHILDRENS HOSPITAL OF ORANGE CCA334$1.31B0.7%
KFH - SANTA CLARACA343$1.25B12.5%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $50.1M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$14.3M+210bp18mo
Cost to Collect4.5%2.5%$13.6M+200bp12mo
Denial Rate Reduction12.0%6.5%$13.5M+198bp12mo
A/R Days Reduction5200.0%3800.0%$8.3M+122bp9mo
Clean Claim Rate88.0%96.0%$436K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$14.3M
Cost to Collect
$13.6M
Denial Rate Reduction
$13.5M
A/R Days Reduction
$8.3M
Clean Claim Rate
$436K
Total EBITDA Uplift$50.1M
Current EBITDA$-23.4M
+ RCM Uplift+$50.1M
Pro Forma EBITDA$26.7M
Current Margin-3.4%
Pro Forma Margin3.9%
WC Released (1x)$26.1M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-36.0M$346.8M0.00x-100.0%
Base (11x exit)10.0x11.0x$-36.0M$369.8M0.00x-100.0%
Bull Case9.0x11.0x$-32.4M$523.5M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-32.4M$561.5M0.00x-100.0%
Bear Case11.0x10.0x$-39.6M$107.9M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-39.6M$105.8M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 206 hospitals with 110-438 beds
  • Same-state prioritization (n=207)
  • Comp margins: P25=-16.9% / P50=-4.0% / P75=4.5%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.